Risk of Strongyloides Hyperinfection Syndrome when prescribing dexamethasone in severe COVID-19

Travel Med Infect Dis. 2021 Mar-Apr:40:101981. doi: 10.1016/j.tmaid.2021.101981. Epub 2021 Jan 31.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Animals
  • COVID-19 Drug Treatment*
  • Dexamethasone / adverse effects
  • Humans
  • SARS-CoV-2
  • Steroids
  • Strongyloides stercoralis*
  • Strongyloidiasis* / drug therapy

Substances

  • Steroids
  • Dexamethasone